IDiyas

For the Inventor, By the Inventor

Hamilton, NJ, United States of America

Christopher M Cimarusti

USPTO Granted Patents = 55

Average Co-Inventor Count = 2.5

ph-index = 8

Forward Citations = 243(Granted Patents)

Forward Citations (Not Self Cited) = 228(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Hamilton Square, NJ (US) (1978 - 1979)
  • Hamilton, NJ (US) (1976 - 1981)
  • Yardley, PA (US) (1984)
  • Pennington, NJ (US) (1983 - 1988)
  • Somerset, NJ (US) (1976 - 1990)
  • Millstone, NJ (US) (1993)

Company Filing History:

goldMedal55 out of 1,624 
 
E. R. Squibb Sons, Inc.
 patents

Years Active: 1976-1993

Loading Chart...
55 patents (USPTO):Explore Patents
1. 5194604 - Process and intermediates for beta-lactams having (1993-03-16),
2. 4937355 - Process for preparing (trans)-4-substituted-dl-proline derivatives (1990-06-26),
3. 4912230 - Process for stereochemically inverting a hydroxy function of an ester by (1990-03-27),
4. 4775670 - 2-oxo-1-azetidinesulfonic acid salts (1988-10-04),
5. 4704457 - Process for the preparation of (3S)-3-[[[2-(protected (1987-11-03),
6. 4625022 - Process for preparing (s)-3-amino-2-oxo-1-azetidinesulfonic acid salts (1986-11-25),
7. 4529698 - Process for preparing a 2-oxo-1-azetidinesulfonic acid salt (1985-07-16),
8. 4483797 - (S)-3-Isocyanato-2-oxo-1-azetidinesulfonic acids (1984-11-20),
9. 4478749 - 2-Oxo-1-(substituted phosphorous)azetidines (1984-10-23),
10. 4474702 - [16,17-a]Cyclopentano pregnenes (1984-10-02),
11. 4443374 - Process for preparing (1984-04-17),
12. 4421686 - 4-Norbornyl-sulfonyl azetidinone intermediates and process for preparing (1983-12-20),
13. 4386034 - Sulfamated amino acid amides (1983-05-31),
14. 4267373 - 5,6,7,8-Tetrahydronaphthalene hypotensive agents (1981-05-12),
15. 4252973 - Process for chemically removing the acyl sidechain from cephalosporins (1981-02-24),

Title: Innovations by Christopher M. Cimarusti: A Pioneer in Pharmaceutical Patents

Introduction: Christopher M. Cimarusti is an esteemed inventor based in Hamilton, NJ, who has made significant contributions to the field of pharmaceuticals. With an impressive portfolio of 55 patents, his work primarily focuses on the development of innovative processes and compounds that are integral to modern medicine.

Latest Patents: Some of Christopher's latest patents include groundbreaking processes for synthesizing beta-lactams. One patent describes a method for preparing a compound through the reaction of a novel compound with a beta-lactam, utilizing specific bases as outlined in the specifications. Another significant patent involves a process for creating (trans)-4-substituted-DL-proline derivatives, which are vital in generating angiotensin converting enzyme inhibitors. This process consists of multiple steps including the reaction of an ester with a potassium amide base, followed by hydrolysis and the removal of protecting groups.

Career Highlights: Christopher M. Cimarusti is a key member of E.R. Squibb & Sons, Inc., where he has fostered a remarkable career. His extensive list of patents showcases his dedication to enhancing pharmaceutical formulations and methods, contributing to advancements in treatment options for various medical conditions.

Collaborations: Throughout his professional journey, Christopher has collaborated with a number of distinguished colleagues, including Frederic P. Hauck and Ravi K. Varma. These partnerships have played a crucial role in driving innovation and refining the processes developed in their research.

Conclusion: Christopher M. Cimarusti’s remarkable contributions to pharmaceutical inventions through his 55 patents exemplify his dedication to innovation in the field. His latest work continues to impact the development of essential medicines, highlighting the importance of inventors in improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…